Plug-and-Play Future for Personalized T-Cell Cancer Therapies
A new automated process for engineering tumor-targeting T cells could help accelerate personalized cancer treatments—while easing the physical toll on patients. Richard C. Koya, MD, PhD, who directs cGMP vector development and production at...
EpilepsyGTx raises $33 million Series A to develop single dose gene therapy for focal...
EpilepsyGTx, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced it has raised $33 million in a Series A financing to advance its lead...
VALANX Biotech establishes Board of Directors
VALANX Biotech (VALANX), a biotech company developing novel antibody-drug-conjugate (ADC) assets enabled by its GoldenSite™ site-specific protein conjugation technology, today announced the formation of its Board of Directors. The Board will support the company’s...
Insilico Details AI-Designed, Cancer-Fighting PROTAC Targeting PKMYT1
Because of its pivotal role in cell cycle regulation—and its overexpression in various types of cancer—membrane-associated tyrosine-threonine protein kinase 1 (PKMYT1) has emerged as a promising therapeutic target in oncology. Past research has shown...
Drug Discovery Innovation: Target Deconvolution and Tractability Assessment
Register Now Panelists:
Zhongyao Ma, PhD Senior Director, Head of Target Discovery and Validation & Peptide Discovery PlatformWuXi Biology, WuXi AppTec View Bio...
Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with targeted...
Maximizing bioprocess efficiency through real-time cell density monitoring
insights from industryYavuz ÇelikGlobal Product ManagerHamilton Bonaduz AG
In this interview, News Medical speaks with Yavuz Çelik, Global Product Manager at Hamilton, about how real-time cell density monitoring enhances yield, viability, and process efficiency in...
Potency and Cell-Based Assay Center Opened by Avance Biosciences
Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional cell-based assays under GMP compliance. Located in Houston,...
Enzyme Linked to Fatal Heart Conditions with Pneumonia Infections Identified
Scientists from the University of Maryland School of Medicine (UMSOM) and the University of Alabama at Birmingham’s Heersink School of Medicine say they have identified a bacterial enzyme that may be the reason some...
Advancing ADC Manufacturing with Integrated Solutions for Safety and Improved Process Control
Sponsored content brought to you byWith the precision of monoclonal antibodies and the potency of small-molecular payloads, antibody-drug conjugates (ADC) are promising cancer therapeutics. As of this year, there are 19 ADC drugs available...
